Vigil Neuroscience News

Vigil Neuroscience | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:19 ET

Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(4.9%),Invus Public Equities Advisors, LLC(4.9%), etc.

Mar 29 16:34 ET

Vigil Neuroscience | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 26 08:24 ET

Vigil Neuroscience | 10-K: Annual report

Mar 26 07:34 ET

Vigil Neuroscience | 8-K: Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 26 07:19 ET

Vigil Neuroscience | 3: Initial statement of beneficial ownership of securities-Officer Kaufmann Petra

Mar 20 16:09 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Kaufmann Petra

Mar 20 16:08 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce

Mar 5 18:59 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Bruhn Suzanne Louise

Mar 5 18:05 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Director Blanchard Cheryl R

Mar 5 17:59 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Verni Christopher

Mar 1 18:10 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Ziolkowski Jennifer Lynn

Mar 1 18:05 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana

Mar 1 17:56 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Gray David L. F.

Mar 1 17:55 ET

Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(6.0%),Citadel Advisors Holdings LP(6.0%), etc.

Feb 14 17:04 ET

Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.62%),Deep Track Biotechnology Master Fund, Ltd.(9.62%), etc.

Feb 14 11:38 ET

Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(3.27%),Deerfield Management Company, L.P.(3.27%), etc.

Feb 12 17:35 ET

Vigil Neuroscience | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(5.0%),Invus Public Equities Advisors, LLC(5.0%), etc.

Feb 9 17:16 ET

Vigil Neuroscience | 8-K: Current report

Jan 11 00:00 ET

Vigil Neuroscience | 4: Statement of changes in beneficial ownership of securities-Officer Magovcevic-Liebisch Ivana

Nov 20, 2023 18:34 ET